Delphi Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Sell
7,988
-3,735
-32% -$573K 1.46% 22
2025
Q4
$1.62M Sell
11,723
-341
-3% -$44.7K 1.57% 7
2025
Q3
$1.55M Sell
12,064
-83
-0.7% -$10.1K 1.44% 18
2025
Q2
$1.47M Sell
12,147
-1,152
-9% -$130K 1.42% 20
2025
Q1
$1.48M Sell
13,299
-1,010
-7% -$108K 1.51% 12
2024
Q4
$1.39M Buy
14,309
+1,128
+9% +$120K 1.35% 41
2024
Q3
$1.52M Sell
13,181
-3,701
-22% -$420K 1.38% 29
2024
Q2
$1.8M Buy
16,882
+403
+2% +$40.5K 1.47% 22
2024
Q1
$1.59M Buy
16,479
+1,329
+9% +$136K 1.24% 54
2023
Q4
$1.53M Buy
15,150
+1,793
+13% +$173K 1.41% 28
2023
Q3
$1.36M Buy
13,357
+636
+5% +$64.6K 1.39% 20
2023
Q2
$1.28M Buy
+12,721
New +$1.27M 1.33% 36
2022
Q4
$1.35M Buy
+14,858
New +$1.25M 1.63% 14
2021
Q4
$1.47M Buy
16,787
+3,314
+25% +$275K 1.38% 23
2021
Q3
$1.1M Buy
13,473
+168
+1% +$15.1K 1.13% 40
2021
Q2
$1.21M Buy
13,305
+431
+3% +$38.4K 1.16% 40
2021
Q1
$1.1M Buy
+12,874
New +$1.16M 1.17% 51

Other funds holding NVS

Delphi Management's NVS Position: Q1 2026 in Review

Delphi Management reduced its Novartis (NVS) stake by 32% in Q1 2026, selling an estimated $573K and leaving 7,988 shares worth $1.22M. The position accounts for 1.46% of the portfolio, ranked #22.

Delphi Management first reported a position in NVS in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.8M in Q2 2024. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Delphi Management held 7,988 shares of Novartis worth $1.22M as of Q1 2026.
  • Delphi Management sold 3,735 Novartis shares in Q1 2026, an estimated $573K.
  • Novartis made up 1.46% of Delphi Management's portfolio in Q1 2026, its #22 holding.
  • Delphi Management first reported a position in Novartis in Q1 2021 and has held it in 17 quarters since.
  • Delphi Management's Novartis position peaked at $1.8M in Q2 2024.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Delphi Management's 13F filing for Q1 2026, filed 20 Apr 2026.